Skip Navigation

Vertex's cystic fibrosis breakthrough

Vertex's cystic fibrosis breakthrough

CNBC's Meg Tirell reports Vertex Pharmaceuticals' treatment for cystic fibrosis has succeeded in late stage trials. Vertex will now file applications for U.S. and Europe approval in Q4.

02:17

Tue, Jun 24 20149:08 AM EDT

The Fed won't cut interest rates this year, says Apollo Global's Torsten Slok

The Fed won't cut interest rates this year, says Apollo Global's Torsten Slok

4 hours ago

Tesla's big gamble: Full Self-Driving in the wild

Tesla's big gamble: Full Self-Driving in the wild

May will be a month that determines how returns for the year will look: NYU's Aswath Damodaran

May will be a month that determines how returns for the year will look: NYU's Aswath Damodaran

Black-owned businesses still face headwinds in obtaining capital

Black-owned businesses still face headwinds in obtaining capital

Stocks picks for companies with 'boomerang CEOs'

Stocks picks for companies with 'boomerang CEOs'

The Fed won't cut interest rates this year, says Apollo Global's Torsten Slok

The Fed won't cut interest rates this year, says Apollo Global's Torsten Slok

4 hours ago

Tesla's big gamble: Full Self-Driving in the wild

Tesla's big gamble: Full Self-Driving in the wild

May will be a month that determines how returns for the year will look: NYU's Aswath Damodaran

May will be a month that determines how returns for the year will look: NYU's Aswath Damodaran

Black-owned businesses still face headwinds in obtaining capital

Black-owned businesses still face headwinds in obtaining capital

Stocks picks for companies with 'boomerang CEOs'

Stocks picks for companies with 'boomerang CEOs'